Company intelligence / Profile preview

Shanxi Zhendong Pharmaceutical Co., Ltd.

Changzhi City, Shanxi Province, Chinazdpharmaceutical.com ↗

Ownership: Private
Employees: ~6000
Development stage: Commercial

Overview

The company has multiple approved drugs in China including Amoxicillin/Flucloxacillin Magnesium and various traditional Chinese medicines. They also have products in clinical development including FuFangKuShen (Phase 3) for Rectal Cancer, Changrui Enema Powder (Phase 2) for Radiation proctitis, and Larotaxel Dihydrate (Phase 1) for Advanced Malignant Solid Neoplasm[9].

Therapeutic areas: Men's HealthOncologyPulmonologyHematologyDermatologyGastroenterologyCardiovascularNephrologyInfectious Diseases
Modalities: Small molecule drugsHerbal medicineTraditional Chinese Medicine
Industry: Biotech

Drug pipeline

11 assets

compound kushen injection

10 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Shanxi Zhendong Pharmaceutical Co., Ltd..

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanxi Zhendong Pharmaceutical Co., Ltd..

Explore the full profile